10:29 AM EDT, 08/29/2024 (MT Newswires) -- Imunon ( IMNN ) filed a registration statement with the US Securities and Exchange Commission Thursday for the potential resale of up to 5 million common shares by certain security holders.

The shares are issuable upon the exercise of certain outstanding warrants, according to a regulatory filing.

The company said it will not receive any proceeds from the share sale by the selling stockholders. However, it will receive the proceeds of any cash exercise of the warrants.

Imunon ( IMNN ) said it would receive $10 million in proceeds if all of the warrants were exercised for cash.